Pharmaceuticals news FT.com

Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments

Jun 23, 2025 - 17:50
 0
Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs
Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments
Read More

Tags:

Previous Article

Illumina to buy SomaLogic in deal worth up to $425M

Next Article

STAT+: Senate Republicans discuss new way to cut Medicaid in Trump’s tax bill

Related Posts

Pfizer to halt development of closely watched weight-loss drug

Pfizer to halt development of closely watched weight-lo...

May 12, 2025  0

Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up

Novo Nordisk cuts forecasts after replica obesity drugs...

May 18, 2025  0

Hims & Hers looks to offer replica obesity drugs in UK and Europe

Hims & Hers looks to offer replica obesity drugs in UK ...

Jun 3, 2025  0